Serious Infections in Two Large US and Swedish Rituximab-treated Multiple Sclerosis Cohorts

被引：0
|
作者：
Langer-Gould, Annette [1 ]
Smith, Jessica [1 ]
Piehl, Fredrik [2 ]
Li, Bonnie [1 ]
Frisell, Thomas [2 ]
机构：
[1] Kaiser Permanente Southern Calif, Pasadena, CA USA
[2] Karolinska Inst, Stockholm, Sweden
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S26.007
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mortality rates in large US and Swedish rituximab-treated multiple sclerosis cohorts.
    Langer-Gould, A.
    Piehl, F.
    Smith, J.
    Frisell, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 35 - 36
  • [2] Rituximab does not increase the risk of malignancy or breast cancer in two large US and Swedish rituximab-treated multiple sclerosis cohorts
    Langer-Gould, A.
    Alping, P.
    Smith, J.
    Li, B.
    Piehl, F.
    Frisell, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 570 - 571
  • [3] Serious safety events in rituximab-treated multiple sclerosis and related disorders
    Vollmer, Brandi L.
    Wallach, Asya I.
    Corboy, John R.
    Dubovskaya, Karolina
    Alvarez, Enrique
    Kister, Ilya
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (09): : 1477 - 1487
  • [4] Serious Adverse Events in Rituximab-Treated Patients with Multiple Sclerosis and Related Disorders
    Vollmer, Brandi L.
    Wallach, Asya
    Corboy, John R.
    Dubovskaya, Karolina
    Alvarez, Enrique
    Kister, Ilya
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 70 - 70
  • [5] Serious Adverse Events in Rituximab-Treated Patients with Multiple Sclerosis and Related Disorders
    Wallach, Asya
    Vollmer, Brandi
    Corboy, John
    Dubovskaya, Karolina
    Kister, Ilya
    Alvarez, Enrique
    NEUROLOGY, 2019, 92 (15)
  • [6] Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry
    Spelman, Tim
    Forsberg, Lars
    McKay, Kyla
    Glaser, Anna
    Hillert, Jan
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (07) : 1051 - 1059
  • [7] Hypogammaglobulinemia and Infections in Patients With Multiple Sclerosis Treated With Rituximab
    Perriguey, Marine
    Maarouf, Adil
    Stellmann, Jan-Patrick
    Rico, Audrey
    Boutiere, Clemence
    Demortiere, Sarah
    Durozard, Pierre
    Pelletier, Jean
    Audoin, Bertrand
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (01):
  • [8] Anti-JC virus antibody index changes in rituximab-treated multiple sclerosis patients
    Baber, Ursela
    Bouley, Andrew
    Egnor, Emily
    Sloane, Jacob A.
    JOURNAL OF NEUROLOGY, 2018, 265 (10) : 2342 - 2345
  • [9] Anti-JC virus antibody index changes in rituximab-treated multiple sclerosis patients
    Ursela Baber
    Andrew Bouley
    Emily Egnor
    Jacob A. Sloane
    Journal of Neurology, 2018, 265 : 2342 - 2345
  • [10] Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients
    Torgauten, Hilde M.
    Onyango, Therese Bredholt
    Ljostveit, Sonja
    Hallin, Erik I.
    Serkland, Trond T.
    Skrede, Silje
    Langeland, Nina
    Cox, Rebecca Jane
    Wergeland, Stig
    Myhr, Kjell-Morten
    Torkildsen, Oivind
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 89
12345